New study investigates diabetes Drug's impact on transplanted kidneys
NCT ID NCT06560801
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks at how the drug dapagliflozin affects the structure and blood flow of transplanted kidneys in people with reduced kidney function one year after transplant. About 48 participants will be randomly assigned to take dapagliflozin or not, and researchers will analyze routine biopsy samples and MRI scans. The goal is to understand the drug's effects on inflammation, oxidative stress, and kidney tissue health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Center (CRC)
RECRUITINGErlangen, Bavaria, 91054, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.